TB-SEQ, Inc.
Biotechnology ResearchCalifornia, United States2-10 Employees
TB-SEQ, Inc. is a life-science company devoted to the development and application of experimental and computational procedures for functional (meta)genomics analysis of prokaryotic and eukaryotic organisms and communities based on the ribosome profiling NGS platform technology (RIBO-seq) and on computational analysis of sequencing data. TB-Seq develops new experimental protocols and bioinformatics tools applicable to different biological system, and offers related services. Our team combines decades of experience in research and development in computational sequence analysis, molecular biology and biochemistry, in experimental analysis of nucleic acids, and in protein and nucleic acid sequence and structure computational analysis. Our proprietary optimized RIBO-seq protocols allow us to produce RIBO-seq libraries of the highest quality more efficiently and with enhanced sensitivity compared to competing protocols. We have the computational capabilities to perform customized analyses on your sequencing data, using available software packages, our suite of bioinformatics tools, or by developing new analytical tools according to your needs. Whatever the information you are looking to extract from your data, we will be happy to discuss with you the most appropriate computational-analysis design, and to execute it for you. TB-SEQ Bioinformatics offers high-end robust bioinformatics to optimize analysis of the information provided by microbiome studies using the most highly rated software packages for all bioinformatics analyses, as well as proprietary software developed by TB-SEQ scientists. Our team has combined decades of experience in scientific research and can assist you in creating a robust and effective experimental design in relation to your samples, your scientific/development goals, and your budget.
1-888-653-2347 
support@leadiq.com 
